| Previous close | 112.20 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,732 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | 2.26 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Calculating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$113 DexCom's US$113 share...
- Barrons.com
Did Your Heart Just Skip a Beat? Your Watch Already Knows That and More.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
- Insider Monkey
Why Is DexCom, Inc. (DXCM) One Of The Best Growth Stocks for Billionaire Ray Dalio?
We recently compiled a list of the 10 Best Growth Stocks To Buy Now According To Billionaire Ray Dalio. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other growth stocks. Ray Dalio is one of the most successful investors in Wall Street’s history. He has […]
© 2024 Yahoo. All rights reserved.